Find Faculty
John E Levine, MD
img_John E Levine
PROFESSOR | Medicine, Hematology and Medical Oncology
PROFESSOR | Pediatrics
Are you a patient?
View my
Provider Profile
Specialties
Pediatrics, Pediatric Hematology-Oncology
Research Topics
Translational Research, Transplantation
Immunosuppression, T Cells, Transplantation
My research focuses on clinical bone marrow transplantation. My primary research focus concentrates on clinical and translational studies for the diagnosis, prevention, and treatment of acute graft-versus-host disease (GVHD). In collaboration with the laboratory of James Ferrara, we developed and validated a GVHD plasma biomarker based scoring system that assigns patients to GVHD risk strata and can be used to determine treatment intensity.

MD, Eastern Virginia Medical School

Residency, Pediatrics, Children's Hospital of Los Angeles

Residency, Pediatrics, Children's Hospital-Los Angeles

Fellowship, Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center

Fellowship, Pediatric Hematology-Oncology, Memorial Sloan-Kettering Cancer Center

Fellowship, Pediatric Blood & Marrow Transplant, Memorial Sloan-Kettering Cancer Center

Certifications

American Board of Pediatrics

2013

Chair, Pediatric Scientific Interest Group, ASBMT Annual Meeting

2012

Chair, Scientific Program, ASBMT Annual Meeting

2007

Best Doctors in America

2005

Ford Motor Company Leadership in Health Award

205
Publications

Selected Publications

Prediction and Prognostication of Acute Graft-Versus-Host Disease by MAGIC Biomarkers. John E. Levine. American Journal of Hematology

Donor telomeres and their magnitude of shortening post-allogeneic haematopoietic cell transplant impact survival for patients with early-stage leukaemia or myelodysplastic syndrome. Shahinaz M. Gadalla, Hormuzd A. Katki, Tsung Po Lai, Paul L. Auer, Casey L. Dagnall, Caitrin Bupp, Amy A. Hutchinson, James J. Anderson, Kyra J.W. Mendez, Stephen R. Spellman, Valerie Stewart, Sharon A. Savage, Stephanie J. Lee, John E. Levine, Wael Saber, Abraham Aviv. eBioMedicine

Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. Mark C. Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K. Waller, John E. Levine, John J. Strouse, Joseph H. Antin, Suhag H. Parikh, Nitya Bakshi, Carlton Dampier, Jennifer J. Jaroscak, Shayla Bergmann, Trisha Wong, Vamsi Kota, Betty Pace, Lazaros J. Lekakis, Premal Lulla, Robert S. Nickel, Kimberly A. Kasow, Uday Popat, Wally Smith, Lolie Yu, Nancy DiFronzo, Nancy Geller, Naynesh Kamani, Elizabeth S. Klings, Kathryn Hassell, Adam Mendizabal, Keith Sullivan, Donna Neuberg, Lakshmanan Krishnamurti. Blood advances

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Levine during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Calliditas Therapeutics AB
  • Glaxosmithkline
  • Mesoblast Inc
  • Equillium, Inc. HQ
  • Incyte Corporation
  • Medexus
  • Kitch Attorneys and Counselors
  • VectivBio AG
  • Forte Biosciences
  • Symbio

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.